0001640334-25-001925.txt : 20251030 0001640334-25-001925.hdr.sgml : 20251030 20251030213005 ACCESSION NUMBER: 0001640334-25-001925 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20251028 FILED AS OF DATE: 20251030 DATE AS OF CHANGE: 20251030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATSUI CONNIE CENTRAL INDEX KEY: 0001236537 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38951 FILM NUMBER: 251437750 MAIL ADDRESS: STREET 1: 3030 CALLAN RD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARTELO BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001621221 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 331220924 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 LOMAS SANTA FE, SUITE 160 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-925-7049 MAIL ADDRESS: STREET 1: 505 LOMAS SANTA FE, SUITE 160 CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: REACTIVE MEDICAL INC. DATE OF NAME CHANGE: 20170207 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT KNOX DEVELOPMENT CORP. DATE OF NAME CHANGE: 20141001 4 1 form4.xml FORM 4 X0508 4 2025-10-28-05:00 false 0001621221 ARTELO BIOSCIENCES, INC. ARTL 0001236537 MATSUI CONNIE C/O ARTELO BIOSCIENCES, INC. 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 true false false false false Convertible Promissory Note 2025-10-28-05:00 4 C false 140000 140000 D 2025-05-01-05:00 2025-10-28-05:00 Common Stock 0.00 D Warrant (right to buy) 6.24 2025-10-28-05:00 4 C false 38346 A 2025-10-28-05:00 2030-10-28-05:00 Common Stock 38346 38346 D Warrant (right to buy) 3.40 2025-10-28-05:00 4 C false 70376 A 2025-10-28-05:00 2030-10-28-05:00 Common Stock 70376 70376 D Convertible Promissory Note 3.40 2025-10-28-05:00 4 C false 110843 110843 A 2025-10-28-05:00 2026-04-28-05:00 Common Stock 110843 D Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the "May Note"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock ("Common Stock") (the "$6.24 Warrant"). On October 28, 2025, the Issuer entered into a Subscription Agreement (the "Subscription Agreement") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the "October Note"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the "$3.40 Warrant"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock. /s/ Gregory D. Gorgas, as Attorney-in-Fact 2025-10-30-05:00